Most people feel Compounded Semaglutide's appetite-suppressing effect within the first 1–2 weeks, but visible weight loss builds gradually: often around 2.0% of body weight by week 4 and 6.5% by week 12 in clinical trials, with results continuing to deepen for a year or more as the dose is titrated up. Individual results vary widely.
What happens, and when
- Week 1–2 (appetite): the earliest change most people notice is reduced hunger and earlier fullness — the drug is active in your system well before the scale moves. Early GI side effects (nausea) are also most common here.
- Weeks 4–12 (the scale moves): measurable weight loss becomes visible. In trials, mean loss was roughly 2.0% by week 4 and 6.5% by week 12. This is also when the dose is stepped up on the titration schedule.
- Months 4–12+ (peak effect): weight loss continues at a slower pace toward the trial peak. In STEP-1, Wegovy (brand semaglutide) reached ~14.9% mean body-weight reduction by 68 weeks (Compounded versions were not in that trial, and the FDA does not review compounded drugs for potency, purity, or effectiveness — do not expect the same result.).
Expected weight-loss curve
Mean body-weight change across 68 weeks on Compounded Semaglutide from the STEP-1 trial. Curve smoothed from published endpoints; individual results vary significantly.
Trial participants also received lifestyle counseling. Real-world results depend on dose adherence, side-effect tolerance, and lifestyle factors.
Why it's gradual — and when to reassess
Compounded Semaglutide is titrated up in steps specifically to limit gastrointestinal side effects, so the full dose — and the full effect — is reached over months, not days. Clinicians often use a rough benchmark of about 5% body-weight loss by around 12–16 weeks on the maintenance dose to judge whether the medication is working for you; if you have lost little by then despite good adherence, that is a reason to talk to your prescriber about dose, technique, or an alternative — not a reason to expect a sudden jump later.
Weight-loss numbers here are smoothed trial means and assume the medication is paired with the diet and activity changes used in the studies. Your pace depends on dose, starting weight, and individual response, and it is normal for the scale to stall for stretches.
Common questions
How long does it take for Compounded Semaglutide to start working?
Compounded Semaglutide becomes active in your body right away, and most people notice reduced appetite and earlier fullness within the first 1–2 weeks. Visible weight loss takes longer — it usually becomes measurable between weeks 4 and 12 and continues to build over months as the dose is titrated up. The appetite effect comes first; the scale follows.
How much weight will I lose in the first month on Compounded Semaglutide?
In clinical trials, mean weight loss in the first month was modest — often around 2–3% of body weight — because the starting dose is deliberately low to limit nausea. Meaningful loss builds over the following months as the dose increases. Early results vary widely between people, and a slow start does not predict your final result.
When does Compounded Semaglutide reach its full effect?
Peak weight loss in the pivotal trials was measured at roughly 68–72 weeks — a bit over a year — with most of the loss occurring in the first several months and the curve flattening after that. Clinicians often look for about 5% loss by 12–16 weeks on the maintenance dose as an early sign the medication is working for you.
What if Compounded Semaglutide isn't working after a few weeks?
Because the effect is gradual, a small change in the first few weeks is expected, not a sign of failure. If you have lost little by around 12–16 weeks on the full maintenance dose despite consistent use and lifestyle changes, talk to your prescriber — they can review your dose, injection technique, or whether a different medication fits better. Don't stop or change the dose on your own.